VANTAGEPOINT INVESTMENT ADVISERS LLCVANTAGEPOINT INVESTMENT ADVISERS LLC

Institutional investor · Portfolio as of Q1 2026

SEC EDGAR SourceSEC Filings

Top Holdings55 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
VUGVUG
ETF

VANGUARD GROWTH ETF

1.2M$504M4.3%$78.97-7.91%
15 qtrssince 2022-Q3
Increased
61
SCHGSCHG
ETF

SCHWAB US LARGE-CAP GROWTH

17.1M$497.2M4.2%$31.82-3.70%
3 qtrssince 2025-Q3
Unchanged
0
QQQMQQQM
ETF

INVESCO NASDAQ 100 ETF

1.9M$461.5M3.9%$246.17+0.63%
3 qtrssince 2025-Q3
Decreased
0
SPYGSPYG
ETF

SPDR PORTFOLIO S&P 500 GROWT

4.3M$417.1M3.5%$103.90-1.14%
3 qtrssince 2025-Q3
Decreased
0
AGGAGG
ETF

ISHARES TR

3.9M$387.7M3.3%$93.40+4.50%
24 qtrssince 2020-Q2
Decreased
0
IEFAIEFA
ETF

ISHARES CORE MSCI EAFE ETF

4.2M$383.2M3.2%$85.55+9.27%
3 qtrssince 2025-Q3
Decreased
0
VYMVYM
ETF

VANGUARD HIGH DVD YIELD ETF

2.2M$330.1M2.8%$139.73+9.70%
3 qtrssince 2025-Q3
Decreased
0
VGTVGT
ETF

VANGUARD INFO TECH ETF

471,293$328.8M2.8%$93.07-6.40%
3 qtrssince 2025-Q3
Decreased
0
FELGFELG
ETF

FIDELITY COVINGTON TRUST

8.6M$323.7M2.7%$40.96-3.98%
3 qtrssince 2025-Q3
Unchanged
0
MGKMGK
ETF

VANGUARD MEGA CAP GROWTH ETF

859,017$315.6M2.7%$80.36-8.64%
3 qtrssince 2025-Q3
Decreased
0
VEAVEA
ETF

VANGUARD FTSE DEVELOPED ETF

4.8M$305.3M2.6%$59.05+12.79%
3 qtrssince 2025-Q3
Increased
55
SPYMSPYM
ETF

SPDR PORTFOLIO S&P 500 ETF

4M$304.8M2.6%$77.84+2.84%
3 qtrssince 2025-Q3
Decreased
0
SPDWSPDW
ETF

SPDR INDEX SHS FDS

6.4M$290.9M2.5%$41.93+13.00%
3 qtrssince 2025-Q3
Increased
53
IEMGIEMG
ETF

ISHARES CORE MSCI EMERGING

4M$282.3M2.4%$64.69+10.95%
3 qtrssince 2025-Q3
Unchanged
0
SPMOSPMO
ETF

INVESCO EXCH TRADED FD TR II

2.4M$270.5M2.3%$120.42-1.00%
3 qtrssince 2025-Q3
Decreased
0
IWPIWP
ETF

ISHARES RUSSELL MIDCAP GRWTH

2.1M$269.6M2.3%$142.39-4.84%
3 qtrssince 2025-Q3
Increased
56
VOTVOT
ETF

VANGUARD MID-CAP GROWTH ETF

1M$268.3M2.3%$291.30-5.61%
3 qtrssince 2025-Q3
Increased
56
SPHQSPHQ
ETF

INVESCO S&P 500 QUALITY ETF

3.3M$249.8M2.1%$72.71+9.04%
3 qtrssince 2025-Q3
Decreased
0
RWLRWL
ETF

INVESCO S&P 500 REVENUE ETF

2.2M$248.3M2.1%$110.04+8.89%
3 qtrssince 2025-Q3
Decreased
0
AVDEAVDE
ETF

AMERICAN CENTY ETF TR

2.9M$246.9M2.1%$77.74+13.08%
3 qtrssince 2025-Q3
Unchanged
0
$11.8B
AUM
55
Positions
Q1 2026
Filing
Rating · 1.5
Quarterly Portfolio Change
-20%Q4'24$624.1M+41%Q1'25$877.1M+14%Q2'25$997.1M+1128%Q3'25$12.2B+1%Q4'25$12.4B-5%Q1'26$11.8B
Activity profile
$ moved · Q1'26
New0%Increased17%Decreased83%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.1 years
<1Q0%1-4Q85%1-2Y2%2Y+13%

VANTAGEPOINT INVESTMENT ADVISERS LLC manages $11.8B across 55 positions as of Q1 2026. Top holdings: VUG (4.3%), SCHG (4.2%), QQQM (3.9%). Fund DNA: Steady Compounder. HoldingsIntel Rating: 1.5/5.0.

Q1 2026 Summary

Increased 9, trimmed 38. Top move: VUG (INCREASED, conviction 61). Portfolio: $11.8B across 55 positions.

Top holdings by portfolio weight

Total AUM$12B
VUG4.27%
SCHG4.21%
QQQM3.91%
SPYG3.53%
AGG3.28%
IEFA3.25%
VYM2.80%
VGT2.79%
FELG2.74%
MGK2.67%
Other2.59%

Portfolio allocation by GICS sector

Sectors1
Unknown100.00%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Unknown
Compare DNA across all funds
7-dimension quality assessment
Below Average(1.5 / 5.0)
Track Record85
Conviction50
Concentration51
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
4Q
VUGVUGVANGUARD GROWTH ETF
Q3 2025 Q2 2026+6.8M shares+$581.2M
3Q
AVEMAVEMAVANTIS EMERGING MARKETS EQ
Q4 2025 Q2 2026+126,777 shares+$60.7M
2Q
VWOVWOVANGUARD FTSE EMERGING MARKETS
Q1 2026 Q2 2026+521,392 shares+$44.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used